A central element to the modern transformation of research and development (R&D) is TransCelerate’s ability to harness the expertise and innovation found in each of its Member Companies and combine it with the insights of key clinical research stakeholders. Since 2012, TransCelerate BioPharma Inc. has designed solutions that have greatly impacted the R&D process. These solutions have improved common pain points, disrupted the clinical development paradigm, and have brought benefits to stakeholders across the industry, including sites, patients, sponsors and regulators. To showcase the value of our Initiatives, our Member Companies are sharing their examples of transformational experiences that explore these key themes:
Acceleration: Driving innovative thinking and accelerating decision making to help bring medications to patients faster.
Access & Accuracy: Providing real-time access to accurate data to propel predictability, improve options and optimize clinical operations, reducing patient burden and shortening development timelines.
Efficiency & Quality: Streamlining processes, improving collaboration, and focusing on quality ‘issues that matter’, which helps improve the clinical trial experience for patients and sites.
Check out how TransCelerate is making an impact on clinical research by improving the patient and site experience, harmonizing processes, sharing information, and enhancing sponsor efficiencies.
Resources: CDT Initiative solutions, guidance and model approaches for patient data anonymization
Animation: RBM Methodology In Action: Improving Protocol Compliance and Time To Data Entry
Podcast: Merck & Co., Inc Discusses the Value of TransCelerate’s Clinical Quality Management System Framework
Access more stories here.
Watch our latest webinar!